Multiple myeloma with high amylase in high altitude areas: a case report

LI Shengxue; WANG Xiaoli; CONG Mengqian; YIN Yujuan

doi:10.7619/jcmp.20232718

Journal of Clinical Medicine in Practice > 2024 > 28(5): 103-106. > DOI: 10.7619/jcmp.20232718

LI Shengxue, WANG Xiaoli, CONG Mengqian, YIN Yujuan. Multiple myeloma with high amylase in high altitude areas: a case report[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 103-106. DOI: 10.7619/jcmp.20232718

Citation:

PDF (696 KB)

Multiple myeloma with high amylase in high altitude areas: a case report

1.
Laboratory Department, the Affiliated Hospital of Qinghai University, Xining, Qinghai, 810001
2.
Hematology Department, the Affiliated Hospital of Qinghai University, Xining, Qinghai, 810001

More Information

Received Date: August 27, 2023
Revised Date: November 23, 2023
Available Online: March 21, 2024

Graphical Abstract

Abstract

Abstract

Multiple myeloma (MM) is a malignant plasmacyte disease that often presents with symptoms such as bone pain and anemia. Currently, there is an increasing number of literature reports on malignant tumors combined with hyperamylasemia, but this is more common in tumors such as gastric cancer, and MM with hyperamylasemia is clinically rare and has not been found in plateau areas. Due to the complex clinical manifestations of MM patients with hyperamylasemia, there is no standard treatment therapy. There is no literature report on the use of daretuumab in combination. Based on the results of the retrospective analysis of the first case of MM with hyperamylasemia in a plateau area, it is recommended that clinicians in plateau areas take amylase level as a sensitive indicator to evaluate the severity of MM in order to reduce the misdiagnosis rate of MM and provide a new treatment option for the promotion and application of MM with hyperamylasemia.
- multiple myeloma,
- hyperamylasemia,
- plateau,
- daratumumab

FullText(HTML)

References (16)

References

[1]	徐晗, 赵彩芳, 李鸽, 等. 多发性骨髓瘤伴高淀粉酶血症的临床分析[J]. 浙江临床医学, 2018, 20(12): 2012-2014. doi: 10.3969/j.issn.1008-7664.2018.12.043
[2]	樊慧守, 李增军, 赵耀中, 等. 产淀粉酶型多发性骨髓瘤伴克隆演变一例[J]. 中华血液学杂志, 2019, 40(10): 878. doi: 10.3760/cma.j.issn.0253-2727.2019.10.018
[3]	安娜, 谢亚萍, 徐颖, 等. 多发性骨髓瘤合并高淀粉酶血症一例[J]. 中华血液学杂志, 2016, 37(10): 845. doi: 10.3760/cma.j.issn.0253-2727.2016.10.003
[4]	熊瑶, 韦宏成, 冯淑芬. 以肺部感染、血淀粉酶升高为表现的多发性骨髓瘤误诊一例[J]. 海南医学, 2016, 27(21): 3594-3595. doi: 10.3969/j.issn.1003-6350.2016.21.053
[5]	吴小娟, 汤绍辉, 刘秋荣, 等. 多发性骨髓瘤伴高淀粉酶血症1例[J]. 实用医学杂志, 2012, 28(10): 1729. doi: 10.3969/j.issn.1006-5725.2012.10.061
[6]	郭茂东, 丁进, 陈燕萍, 等. 多发性骨髓瘤合并高淀粉酶血症一例报道并文献复习[J]. 中国全科医学, 2019, 22(11): 1372-1376. doi: 10.12114/j.issn.1007-9572.2018.00.256
[7]	PINELLI M, BINDI M, ROSADA J, et al. Amylase: a disease activity index in multiple myeloma?[J]. Leuk Lymphoma, 2006, 47(1): 151-154. doi: 10.1080/10428190500262144
[8]	MISHRA S B, AZIM A, MUKHERJEE A. Multiple myeloma presenting as acute pancreatitis[J]. Am J Emerg Med, 2017, 35(9): 1385. e1-1385. e2. doi: 10.1016/j.ajem.2017.06.009
[9]	NAIR S, SACHAN P, HERTAN H, et al. Metastatic multiple myeloma with hyperamylasaemia and hyperlipasaemia[J]. Postgrad Med J, 1998, 74(876): 621-623. doi: 10.1136/pgmj.74.876.621
[10]	SAKAI M, ISHIKAWA S, YAMAMOTO T, et al. A direct measurement of serum amylase levels produced by lung cancer[J]. Ann Thorac Surg, 2005, 79(4): 1409-1411. doi: 10.1016/j.athoracsur.2003.10.069
[11]	MORIYAMA T. Sialyl salivary-type amylase associated with ovarian cancer[J]. Clin Chim Acta, 2008, 391(1/2): 106-111.
[12]	韩雨, 王成, 张芷祎, 等. 低剂量沙利度胺联合地塞米松治疗老年初治多发性骨髓瘤的临床研究[J]. 实用临床医药杂志, 2010, 14(19): 47-48. doi: 10.3969/j.issn.1672-2353.2010.19.017
[13]	LOKHORST H M, PLESNER T, LAUBACH J P, et al. Targeting CD38 with daratumumab monotherapy in multiple myeloma[J]. N Engl J Med, 2015, 373(13): 1207-1219. doi: 10.1056/NEJMoa1506348
[14]	LONIAL S, WEISS B M, USMANI S Z, et al. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial[J]. Lancet, 2016, 387(10027): 1551-1560. doi: 10.1016/S0140-6736(15)01120-4
[15]	OK S J, KIM I S, LEE E Y, et al. A case of salivary-type amylase-producing multiple myeloma presenting as mediastinal plasmacytoma and myelomatous pleural effusion[J]. Ann Lab Med, 2014, 34(6): 463-465. doi: 10.3343/alm.2014.34.6.463
[16]	SOSNOFF D R, FRIEND R B, BERKOVIC M, et al. Salivary amylase-producing multiple myeloma: case report and review of the current literature[J]. J Clin Oncol, 2013, 31(19): e309-e311. doi: 10.1200/JCO.2012.46.4677

Cited By

Cited by

Periodical cited type(7)

1.	宋士磊. 64排CT后处理技术诊断原发性肝癌的临床价值. 医药前沿. 2025(07): 66-68+72 .
2.	贾哲，张海涛，李培鑫，刘坤，马超. 基于倾向性评分匹配对比肝切除并微波消融与TACE治疗多发性肝癌的临床效果. 山东医药. 2024(01): 52-55 .
3.	尹玲. 增强CT扫描对TAEC术后原发性肝癌患者疗效评估研究. 医药论坛杂志. 2024(05): 543-546 .
4.	桂颖颖，张圆. CT增强扫描和MRI检查在原发性肝癌患者诊断中的应用价值比较. 中国卫生标准管理. 2024(14): 106-109 .
5.	朱桂荣. 原发性肝癌患者临床诊断中CT增强扫描的应用价值. 现代诊断与治疗. 2024(17): 2633-2635 .
6.	卢方. 磁共振成像与多层螺旋CT在原发性肝癌诊断中的效能比较. 中国民康医学. 2023(21): 97-99 .
7.	高翔，李含静，张明佳. 原发性肝癌综合性介入治疗疗效评价. 中外医疗. 2023(26): 66-69 .

Other cited types(0)

Get Citation

PDF

XML

Article views (122) PDF downloads (13) Cited by(7)

Turn off MathJax

Article Contents

Abstract

References

Multiple myeloma with high amylase in high altitude areas: a case report

Abstract

References

Cited by

Periodical cited type(7)

Other cited types(0)

Catalog

Export File

Citation

Format

Content